Join International Pharmaceutical Federation (FIP) today at 4:00 PM CET (Feb 19, 2025) for an insightful discussion on equitable access to mpox vaccines. With the WHO declaring mpox a public health emergency, this webinar will explore strategies to bridge the gap in vaccine distribution, particularly in the most affected regions. Our expert panel will highlight ...
Mise à jour de la littérature par Raffaella The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Dear Friends, It seems that in 2023 I missed this document, “Global burden of preventable medication-related harm in health care“, which was a deliverable from the Global Patient Safety Challenge: Medication ...
As part of our ongoing efforts to enhance coordination and response related to pharmaceutical assessments, we bring you this message. In Venezuela, Acción Contra el Hambre (ACH) and Médecins du Monde (MdM) Spain are working with Quamed to organise assessments of local pharmaceutical distributors. They will begin field-level coordination to identify organizations and suppliers interested ...
We are pleased to announce that Deltafarma Ecza Deposu has received a QCP GSDP certificate. Their operations are fully compliant with the WHO GSDP standards. Deltafarma is located at Yeşiloba Mahallesi 2. Cadde Adana Gida Sanayi Is Merkezi B Blok No. 11/2E, Seyhan in Adana, Turkiye. Their website is https://www.deltafarma.com.tr/. The certificate they received is ...
The following message is courtesy of our friends from the Be-cause health Dear Because Health Friends, We are delighted to invite you to the dissemination event of the PharmaChron project, titled “Access to Essential Medicines at the Primary Health Care Level in Conflict-Affected Regions of Northern Syria.” It is scheduled on 19/02, at 9.30-12.30 Belgian ...
Most people in the world access medicines through the private retail sector. This sector is essential for the distribution of medicines in many countries. This article examines their role in pandemic preparedness. https://pubmed.ncbi.nlm.nih.gov/39881951
The following message is courtesy of Dr. Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium Dear Friends, This is an important mailing for those who do research, education and policy support in the field of quality of medicines! The WHO has issued at the end of 2024 a new report of the Global ...
The African Union Development Agency-NEPAD has officially become a PIC/S Associated Partner, marking a significant step in global cooperation on Good Manufacturing Practice (GMP) standards. This partnership will enhance regulatory capacity, support African Medicines Agency (AMA) members in PIC/S accession, and train inspectors in GMP. Together, they aim to strengthen public health and harmonize quality ...
The NCD Alliance invites you to a webinar on 23 January 2025, at 14:00 CET, focusing on access to medicines, diagnostics, and medical devices for non-communicable diseases. With rising NCD burdens in low- and middle-income countries, this event highlights critical challenges and solutions, including key recommendations developed with the University of Geneva and leading NGOs. ...
A new study highlights the challenges of accessing essential medicines in the South Pacific, with lower-middle-income countries facing the lowest availability (59.1% public, 57.4% private) and significant affordability barriers. While upper-middle and high-income countries show better access, medicine prices remain high across the region. Urgent policy reforms and strategic initiatives are needed to address these ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.